EQUILLIUM INC

COO Christine Zedelmayer’s disciplined buy‑sell pattern at EQUILLIUM—purchasing low, selling high, and exercising options—signals insider confidence and hints at upcoming clinical milestones that could boost stock value.

Equillium’s insider buys reveal execs betting on a 36‑month option plan, aligning leadership with shareholder gains while driving pipeline milestones toward market entry.